GHAMMAD
Board
1 director, since incorporationDirector (not named in the articles)
since 02-02-2022
listed in the 2025 annual accounts, filed on 03-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 12 Pouvoirs du (ou des) administrateur(s) L’administrateur unique ou les administrateurs disposent, chacun séparément, des pouvoirs…”deed of 04-02-2022
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 02-02-2022 to date
Control
Founder
This company
GHAMMAD
Equity €115,912
Profit €110,340 in 2025
Capital
- Contribution
- €5,000
- Shares
- 1,000
- Contribution per share
- €5
- Equity per share
- €116 in 2025
- Source
- deed of 04-02-2022
Articles of association
deed of 04-02-2022 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Six ans, gratuit ou onéreux selon décision assemblée générale”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Respect règles Code de déontologie médicale, accord unanime des autres actionnaires”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Saturday of May at 18:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Assemblée générale le cas échéant, assisté par médecins inscrits au Tableau de l'Ordre pour matières médicales et secret professionnel”
Shareholders
At incorporation
deed of 04-02-2022 ↗
- 1,000 shares (100%)